Close

Stocks Crossing 50-Day SMA 10/15: (RF) (SNDK) (CSCO) Above; (EBAY) (DCTH) (HRS) Below

Go back to Stocks Crossing 50-Day SMA 10/15: (RF) (SNDK) (CSCO) Above; (EBAY) (DCTH) (HRS) Below

Visa (V) Expands V.me Mobile Wallet with New Partnerships; Adds Pressure to Peers (EBAY) (MA)

October 15, 2012 12:11 PM EDT

Visa (NYSE: V) is higher on the session following news earlier that it is working to expand its e-commerce/mobile payments footprint with the addition of new partners.

V.me -- Visa's digital wallet service -- added 1-800-FLOWERS.COM (Nasdaq:... More

Cisco (CSCO) Making Moves in Layer 4-7, Could Impact F5 (FFIV), Radware (RDWR)

October 15, 2012 10:54 AM EDT

Analysts at Oppenheimer commented on Cisco (NASDAQ: CSCO) Monday, which could have positive implications for Citrix (NASDAQ: CTXS) and negative implications for F5 (NASDAQ: FFIV) and Radware (NASDAQ: RDWR).
... More

Wedbush Upgrades SanDisk (SNDK) to Outperform

October 15, 2012 9:27 AM EDT

Wedbush upgraded SanDisk (NASDAQ: SNDK) from Neutral to Outperform with a price target of $49.00 (from $39.00).

The firm comments, "We upgrade SanDisk (SNDK) to an OUTPERFORM rating ahead of the company's Q3 report set for AMC on Thursday, October 18. We expect... More

Jefferies Lifts Numbers on SanDisk (SNDK), Gross Margin Upside Potential

October 15, 2012 7:27 AM EDT

Jefferies boosted estimates and its price target on Buy-rated SanDisk (NASDAQ: SNDK) from $46 to $51.

The analyst comments, "SNDK has rallied 30% off the bottom, and investor expectations have increased. We maintain our Buy rating for two reasons: 1) we continue to believe a... More

Delcath (DCTH) Moves Higher as FDA Grants Chemosaturation System NDA Standard Review

October 15, 2012 7:24 AM EDT

Shares of Delcath Systems, Inc. (Nasdaq: DCTH) are ripping higher in early trading Monday following an announcement that its chemosaturation system with melphalan hydrochloride for injection NDA was accepted by the FDA for standard review.

In the release, the implied PDUFA date... More

Lazard Capital Downgrades Harris Corp. (HRS) to Sell

October 15, 2012 6:53 AM EDT

Lazard Capital downgraded Harris Corp. (NYSE: HRS) from Neutral to Sell.

For an analyst ratings summary and ratings history on Harris Corp. click here. For more ratings news on Harris Corp. click here.

Shares of Harris Corp. closed at $48.84 yesterday, with a 52 week range of $33.24-$52.23.... More